Showing results (151-160 of 318) with videos related to
Sort By:
Pageof 32
Expert Review of Anticancer Therapy|May 1, 2015
Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunityAndrea Ravelli, James M Reuben, Francesco Lanza, et al.Medical Oncology (Northwood, London, England)|July 31, 2015
Ibrutinib: from bench side to clinical implicationsDavide Grisafi, Alessandra Maestro, Camilla Grumi, et al.Oncotarget|June 25, 2020
Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET studySilvia P Corona, Fabiola Giudici, Guy Jerusalem, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Changes in microvessel density as assessed by CD34 antibodies after primary chemotherapy in human breast cancerAlberto Bottini, Alfredo Berruti, Alessandra Bersiga, et al.Journal of the National Cancer Institute. Monographs|June 12, 2015
Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?Daniele Generali, Mara Ardine, Carla Strina, et al.European Journal of Clinical Investigation|June 15, 2020
Italian survey on managing immune checkpoint inhibitors in oncology during COVID-19 outbreakMarco Tagliamento, Francesco Spagnolo, Francesca Poggio, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2023
SNP of Aromatase Predict Long-term Survival and Aromatase Inhibitor Toxicity in Patients with Early Breast Cancer: A Biomarker Analysis of the GIM4 and GIM5 TrialsBenedetta Conte, Luca Boni, Giancarlo Bisagni, et al.JCO Oncology Practice|June 24, 2020
Assessing the Impact of the COVID-19 Outbreak on the Attitudes and Practice of Italian Oncologists Toward Breast Cancer Care and Related Research ActivitiesFrancesca Poggio, Marco Tagliamento, Massimo Di Maio, et al.Breast Cancer Research and Treatment|August 4, 2010
Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patientsTeresa Mele, Daniele Generali, Stephen Fox, et al.Critical Reviews in Oncology/Hematology|December 8, 2015
Current challenges in HER2-positive breast cancerFabio Puglisi, Caterina Fontanella, Vito Amoroso, et al.Pageof 32